JP2024516610A5 - - Google Patents
Info
- Publication number
- JP2024516610A5 JP2024516610A5 JP2023564436A JP2023564436A JP2024516610A5 JP 2024516610 A5 JP2024516610 A5 JP 2024516610A5 JP 2023564436 A JP2023564436 A JP 2023564436A JP 2023564436 A JP2023564436 A JP 2023564436A JP 2024516610 A5 JP2024516610 A5 JP 2024516610A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- mhc class
- amino acid
- acid substitution
- tmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177660P | 2021-04-21 | 2021-04-21 | |
| US63/177,660 | 2021-04-21 | ||
| PCT/US2022/025552 WO2022226073A1 (en) | 2021-04-21 | 2022-04-20 | Mhc class ii t-cell modulatory polypeptides and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516610A JP2024516610A (ja) | 2024-04-16 |
| JP2024516610A5 true JP2024516610A5 (https=) | 2025-04-28 |
Family
ID=83723384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564436A Pending JP2024516610A (ja) | 2021-04-21 | 2022-04-20 | Ｍｈｃクラスｉｉ ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240139298A1 (https=) |
| EP (1) | EP4326337A4 (https=) |
| JP (1) | JP2024516610A (https=) |
| CN (1) | CN117396229A (https=) |
| AU (1) | AU2022261910A1 (https=) |
| CA (1) | CA3212765A1 (https=) |
| WO (1) | WO2022226073A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020534352A (ja) | 2017-09-07 | 2020-11-26 | キュー バイオファーマ，インコーポレーテッド | コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007524583A (ja) * | 2003-03-07 | 2007-08-30 | ロンドン・ヘルス・サイエンシズ・センター・リサーチ・インコーポレーテッド | 自己免疫異常に関わるｈｌａ−ｄｒｍｈｃクラスｉｉ分子に関するペプチド |
| CN110396133B (zh) * | 2018-04-25 | 2021-07-23 | 免疫靶向有限公司 | 一种以白介素12为活性成分的融合蛋白型药物前体 |
| WO2020132366A2 (en) * | 2018-12-19 | 2020-06-25 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof |
| WO2020132365A2 (en) * | 2018-12-19 | 2020-06-25 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof |
| EP3897690A4 (en) * | 2018-12-19 | 2022-09-28 | Cue Biopharma, Inc. | T LYMPHOCYTE MODULATOR MULTIMERIC POLYPEPTIDES HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| JP2022522405A (ja) * | 2019-03-06 | 2022-04-19 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞調節多量体ポリペプチド及びその使用方法 |
| EP3935079A4 (en) * | 2019-03-06 | 2023-03-22 | Cue Biopharma, Inc. | T-CELL MODULATING ANTIGEN PRESENT POLYPEPTIDES AND METHODS OF USE THEREOF |
| WO2022226058A1 (en) * | 2021-04-22 | 2022-10-27 | Cue Biopharma, Inc. | Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof |
-
2022
- 2022-04-20 WO PCT/US2022/025552 patent/WO2022226073A1/en not_active Ceased
- 2022-04-20 CA CA3212765A patent/CA3212765A1/en active Pending
- 2022-04-20 EP EP22792414.9A patent/EP4326337A4/en active Pending
- 2022-04-20 AU AU2022261910A patent/AU2022261910A1/en active Pending
- 2022-04-20 CN CN202280039527.8A patent/CN117396229A/zh active Pending
- 2022-04-20 JP JP2023564436A patent/JP2024516610A/ja active Pending
-
2023
- 2023-10-02 US US18/375,853 patent/US20240139298A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clevers et al. | The T cell receptor/CD3 complex: a dynamic protein ensemble | |
| Gregor et al. | Molecular structure of the chick cerebellar kainate-binding subunit of a putative glutamate receptor | |
| Manolios et al. | Pairwise, cooperative and inhibitory interactions describe the assembly and probable structure of the T‐cell antigen receptor. | |
| JP2023527049A5 (https=) | ||
| JP2022536581A5 (https=) | ||
| Ikuta et al. | Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. | |
| JP2021191265A5 (https=) | ||
| GB2611448A (en) | Polypeptide useful in adoptive cell therapy | |
| EP1530592B1 (en) | Chimeric mhc protein and oligomer thereof | |
| Rubin et al. | The molecular basis for the generation of the human soluble interleukin 2 receptor | |
| JP2022515330A5 (https=) | ||
| EP0379904B1 (en) | A soluble molecule related to but distinct from ICAM-1 | |
| CN117986384A (zh) | 与il-12和il-18的基于il-15的融合物 | |
| JPS61257998A (ja) | ヘテロダイマ性ｔリンパ球レセプタ | |
| Kinet | The γ-ξ dimers of Fc receptors as connectors to signal transduction | |
| JP2019512222A5 (https=) | ||
| JPH09121871A (ja) | Ｔ細胞抗原レセプターα−サブユニット関連核酸及び抗体 | |
| WO1996018105A1 (en) | Single chain t-cell receptor | |
| RU94045919A (ru) | Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция | |
| JP2023526723A5 (https=) | ||
| CN111892661A (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| WO2020259541A1 (zh) | 一种用于肿瘤治疗的嵌合抗原受体t淋巴细胞及其制备方法与应用 | |
| JP2023541366A5 (https=) | ||
| JP2023524132A5 (https=) | ||
| JP2024516610A5 (https=) |